Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress

Roche announced today that the first data on a novel blood-based assay, co-developed with Foundation Medicine (NASDAQ: FMI), will be presented during the European Society for Medical Oncology (ESMO) Congress from 8-12 September 2017 in Madrid, Spain.
Source: Roche Media News - Category: Pharmaceuticals Source Type: news